Small Molecules Identified from a Quantitative Drug Combinational Screen Resensitize Cisplatin's Response in Drug-Resistant Ovarian Cancer Cells

Drug resistance to chemotherapy occurs in many ovarian cancer patients resulting in failure of treatment. Exploration of drug resistance mechanisms and identification of new therapeutics that overcome the drug resistance can improve patient prognosis. Following a quantitative combination screen of 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Sima, Ni, Sun, Wei, Gorshkov, Kirill, Shen, Min, Huang, Wei, Zhu, Wenge, Xie, Xing, Zheng, Wei, Cheng, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034569/
https://www.ncbi.nlm.nih.gov/pubmed/29982103
http://dx.doi.org/10.1016/j.tranon.2018.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034569/
https://www.ncbi.nlm.nih.gov/pubmed/29982103
http://dx.doi.org/10.1016/j.tranon.2018.06.002

Ejemplares similares